Long-term survival after dose-dense high-dose chemotherapy with progenitor cell support as primary treatment for patients with advanced ovarian cancer

被引:0
|
作者
Eisenhauer, E. L. [1 ]
Tew, W. P. [1 ]
Sabbatini, P. J. [1 ]
Spriggs, D. R. [1 ]
Chi, D. S. [1 ]
Barakat, R. R. [1 ]
Aghajanian, C. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, New York, NY USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
90
引用
收藏
页码:S41 / S42
页数:2
相关论文
共 50 条
  • [21] High-dose chemotherapy in advanced epithelial ovarian cancer
    Curé, H
    Bay, JO
    Plagne, R
    Chollet, P
    Dauplat, J
    BULLETIN DU CANCER, 2001, 88 (09) : 842 - 851
  • [22] German multicenter trial of high dose chemotherapy with stem cell support as primary treatment of advanced ovarian cancer
    Frickhofen, N
    Koenigsmann, K
    Opri, F
    Haas, R
    Wallwiener, D
    Nerl, C
    Thomssen, C
    Hossfeld, DK
    Wandt, H
    Trümper, L
    Villena-Heinsen, C
    von Schilling, C
    Kuhn, W
    Bunjes, D
    Bergmann, L
    Kreienberg, R
    Hinke, A
    Moebus, VJ
    BONE MARROW TRANSPLANTATION, 1998, 22 : S95 - S96
  • [23] Long-term disease-free survival of patients with advanced mantle-cell lymphoma following high-dose chemotherapy
    N Kröger
    M Hoffknecht
    P Dreger
    W Krüger
    W Zeller
    A Krüll
    M Stockschläder
    S Bittner
    HJ Weh
    AR Zander
    Bone Marrow Transplantation, 1998, 21 : 55 - 57
  • [24] Long-term disease-free survival of patients with advanced mantle-cell lymphoma following high-dose chemotherapy
    Kröger, N
    Hoffknecht, M
    Dreger, P
    Krüger, W
    Zeller, W
    Krüll, A
    Stockschläder, M
    Bittner, S
    Weh, HJ
    Zander, AR
    BONE MARROW TRANSPLANTATION, 1998, 21 (01) : 55 - 57
  • [25] LONG-TERM SURVIVAL IN ADVANCED OVARIAN-CANCER AFTER CYTOREDUCTION AND CHEMOTHERAPY TREATMENT
    DELCAMPO, JM
    FELIP, E
    RUBIO, D
    VIDAL, R
    BERMEJO, B
    COLOMER, R
    ZANON, V
    GYNECOLOGIC ONCOLOGY, 1994, 53 (01) : 27 - 32
  • [26] High-dose chemotherapy with autologous stem cell support for the treatment of advanced ovarian cancer - Initial experience in Uppsala and Turku
    Grenman, S
    Tholander, B
    Remes, K
    Kauppila, M
    Rajamaki, A
    Pelliniemi, TT
    Rantanen, V
    Salmi, T
    Carlsson, K
    Hoglund, M
    Oberg, G
    Simonson, B
    Salmi, T
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1997, 76 (04) : 363 - 368
  • [27] Dose-Dense Paclitaxel With Carboplatin for Advanced Ovarian Cancer: A Feasible Treatment Alternative
    Glaze, Sarah
    Teitelbaum, Lisa
    Chu, Pamela
    Ghatage, Prafull
    Nation, Jill
    Nelson, Gregg
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2013, 35 (01) : 61 - 67
  • [28] Long-term Survival in Patients with Mantle Cell Lymphoma after Total Body Irradiation, High-dose Chemotherapy and Stem Cell Transplantation
    Kroger, K.
    Siats, J.
    Stelljes, M.
    Lenz, G.
    Eich, H. T.
    Reinartz, G.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (SUPPL 1) : S172 - S172
  • [29] Long-term survival after high-dose salvage chemotherapy for germ cell malignancies with adverse prognostic variables
    Vaena, DA
    Abonour, R
    Einhorn, LH
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (22) : 4100 - 4104
  • [30] High-dose chemotherapy with hematopoietic rescue in patients with stage III to IV ovarian cancer: Long-term results
    Legros, M
    Dauplat, J
    Fleury, J
    Cure, H
    Suzanne, F
    Chassagne, J
    Bay, JO
    Sol, C
    Canis, M
    Condat, P
    Choufi, B
    Tavernier, F
    Glenat, C
    Chollet, P
    Plagne, R
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (04) : 1302 - 1308